{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:07:10Z","timestamp":1780582030310,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.parkreldis.2026.108322","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:01:49Z","timestamp":1776841309000},"page":"108322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disease duration\u2013dependent alteration of regulatory natural killer cells in patients with Parkinson's disease"],"prefix":"10.1016","volume":"147","author":[{"given":"Yuki","family":"Yamanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-591X","authenticated-orcid":false,"given":"Noriyuki","family":"Miyaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Emamussalehin","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.parkreldis.2026.108322_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12264-022-00957-z","article-title":"Association of glial activation and \u03b1-Synuclein pathology in Parkinson's disease","volume":"39","author":"Wang","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108322_bib2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in peripheral inflammatory cytokine levels in parkinson disease: a systematic review and meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108322_bib3","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.parkreldis.2026.108322_bib4","article-title":"Pathological role of natural killer cells in Parkinson's disease: a systematic review","volume":"14","author":"Zhang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108322_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2014.00222","article-title":"Higher expression of activating receptors on cytotoxic NK cells is associated with early control on HIV-1C multiplication","volume":"5","author":"Kulkarni","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108322_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue determinants of human NK cell development, function, and residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108322_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108322_bib8","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.3390\/ijms24032477","article-title":"The interplay between \u03b1-Synuclein and microglia in \u03b1-Synucleinopathies","volume":"24","author":"Deyell","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108322_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108322_bib10","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.parkreldis.2026.108322_bib11","article-title":"The role of peripheral inflammation-related biomarkers in distinguishing parkinson's disease","volume":"123","author":"Zhang","year":"2024","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108322_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41531-024-00652-y","article-title":"Distinctive CD56(dim) NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson's disease patients","volume":"10","author":"Weber","year":"2024","journal-title":"npj Parkinson's Dis."},{"issue":"9","key":"10.1016\/j.parkreldis.2026.108322_bib13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/eji.1830170909","article-title":"Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells","volume":"17","author":"Frei","year":"1987","journal-title":"Eur. J. Immunol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:43:01Z","timestamp":1780580581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026001495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":13,"alternative-id":["S1353802026001495"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108322","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease duration\u2013dependent alteration of regulatory natural killer cells in patients with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108322"}}